Elevated hyaluronan and extracellular matrix metalloproteinase inducer levels in women with preeclampsia

Archives of Gynecology and Obstetrics

Volumn 289, Issue 3, 2014, Pages 575-579

  Romão, Mariana ^a   Weel, Ingrid Cristina ^a   Lifshitz, Shirlee Jaffe ^b   Peraçoli, Maria Terezinha Serrão ^a   Witkin, Steven S ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

EMMPRIN; Gestational hypertension; Hyaluronan; Inflammation; Preeclampsia

Indexed keywords

CD147 ANTIGEN; GELSOLIN; HISTONE; HISTONE H2B; HYALURONIC ACID; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ADULT; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PREECLAMPSIA; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN TRANSPORT; TISSUE INJURY; UPREGULATION;

ADOLESCENT; ADULT; ANTIGENS, CD147; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GELSOLIN; HISTONES; HUMANS; HYALURONIC ACID; HYPERTENSION, PREGNANCY-INDUCED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PRE-ECLAMPSIA; PREGNANCY;

EID: 84896701732     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-013-3021-7     Document Type: Article

References (37)

1. Carty DM, Delles C, Dominiczak AF (2010) Preeclampsia and future maternal health. J Hypertens 28:1349-1355
2. Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM (2011) Pre-eclampsia: pathophysiology, diagnosis and management. Vasc Health Risk Manag 7:467-474
3. Rein DT, Breidenbach M, Hönsheid B, Friebe-Hoffmann U, Engel H, Göhring UJ, Uekermann L, Kurbacher CM, Schöndorf T (2003) Preeclamptic women are deficient of interleukin-10 as assessed by cytokine release of trophoblast cells in vitro. Cytokine 23:119-125
4. Paternoster DM, Fantinato S, Manganelli F, Nicolini U, Milani M, Girolami A (2004) Recent progress in the therapeutic management of pre-eclampsia. Expert Opin Pharmacother 5:2233-2239
5. Pijnenborg R, Bland JM, Robertson WB, Brosens I (1983) Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta 4:397-413
6. Khan F, Belch JJ, MacLeod M, Mires G (2005) Changes in endothelial function precede the clinical disease in women in whom preeclampsia develops. Hypertension 46:1123-1128
7. Dekker GA, Sibai BM (1999) The immunology of preeclampsia. Semin Perinatol 23:24-33
8. Gupta S, Agarwal A, Sharma RK (2005) The role of placental oxidative stress and lipid peroxidation in preeclampsia. Obstet Gynecol Surv 60:807-816
9. Redman CW, Sargent IL (2000) Placental debris, oxidative stress and pre-eclampsia. Placenta 21:597-602
10. Redman CW, Sargent IL (2005) Latest advances in understanding preeclampsia. Science 308:1592-1594
11. Redman CW, Sargent IL (2003) Preeclampsia, the placenta and the maternal systemic inflammatory response - a review. Placenta 24(suppl A):S21-S27
12. Huet E, Gabison EE, Mourah S, Menashi S (2008) Role of Emmprin/CD147 in tissue remodeling. Connect Tissue Res 49:175-179
13. Yuan W, Ge H, He B (2010) Pro-inflammatory activities induced by CyPA-EMMPRIN interaction in monocytes. Atherosclerosis 213:415-421
14. Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, Gallo RL (2004) Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 279:17079-17084
15. Scheibner KA, Lutz MA, Boodoo S, Fenton MJ, Powell JD, Horton MR (2006) Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol 177:1272-1281
16. Stern R, Asari AA, Sugahara KN (2006) Hyaluronan fragments: an information-rich system. Eur J Cell Biol 85:699-715
17. Lee WM, Galbraith RM (1992) The extracellular actin-scavenger system and actin toxicity. N Engl J Med 326:1335-1341
18. Peddada N, Sagar A, Ashish, Garg R (2012) Plasma gelsolin: a general prognostic marker for health. Med Hypotheses 78:203-210
19. Lind SE, Janmey PA (1984) Human plasma gelsolin binds to fibronectin. J Biol Chem 259:13262-13266
20. Osborn TM, Dahlgren C, Hartwig JH, Stossel TP (2007) Modifications of cellular responses to lysophosphatidic acid (LPA) and platelet activating factor (PAF) by plasma gelsolin (pGSN). Am J Physiol 292:1323-1331
21. Bucki R, Georges PC, Espinassous Q, Funaki M, Pastore JJ, Chaby R, Janmey PA (2005) Inactivation of endotoxin by human plasma gelsolin. Biochemistry 44:9590-9597
22. Bucki R, Byfield FJ, Kulakowska A, McCormick ME, Drozdowski W, Namiot Z, Hartung T, Janmey PA (2008) Extracellular gelsolin binds lipoteichoic acid and modulates cellular response to proinflammatory bacterial wall components. J Immunol 181:4936-4944
23. Moschen AR, Kaser A, Enrich B, Mosheimer B, Theurl M, Niederegger H, Tilg H (2007) Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 178:1748-1758
24. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307:426-430
25. Fasshauer M, Waldeyer T, Seeger J, Schrey S, Ebert T, Kratzsch J, Lossner U, Bluher M, Stumvoll M, Faber R, Stepan H (2008) Serum levels of the adipokine visfatin are increased in pre-eclampsia. Clin Endocrinol 69:69-73
26. Kim HS, Cho JH, Park HW, Yoon H, Kim MS, Kim SC (2002) Endotoxin-neutralizing antimicrobial proteins of the human placenta. J Immunol 168:2356-2364
27. Witkin SS, Linhares IM, Bongiovanni AM, Herway C, Skupski D (2011) Unique alterations in infection-induced immune activation during pregnancy. BJOG 118:145-153
28. American College of Obstetricians and Gynecologists (2002) Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletin no. 33. Washington, DC
29. Peraçoli MT, Bannwart CF, Cristofalo R, Borges VT, Costa RA, Witkin SS, Peraçoli JC (2011) Increased reactive oxygen species and tumor necrosis factor-alpha production by monocytes are associated with elevated levels of uric acid in pre-eclamptic women. Am J Reprod Immunol 66:460-467
30. Giorgi VS, Peracoli MT, Peracoli JC, Witkin SS, Bannwart-Castro CF (2012) Silibinin modulates the NF-κB pathway and pro-inflammatory cytokine production by mononuclear cells from preeclamptic women. J Reprod Immunol 95:67-72
31. Berg S, Engman A, Holmgren S, Lundahl T, Laurent TC (2001) Increased plasma hyaluronan in severe pre-eclampsia and eclampsia. Scand J Clin Lab Invest 61:131-137
32. Fraser JR, Laurent TC, Laurent UB (1997) Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 242:27-33
33. Wilson MC, Meredth D, Fox JE, Manoharan C, Davies AJ, Halestrap AP (2005) Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4; the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70). J Biol Chem 280:27213-27221
34. Iacono KT, Brown AL, Greene MI, Saouaf SJ (2007) CD147 immunoglobulin superfamily receptor function and role in pathology. Exp Molec Pathol 83:283-295
35. Braundmeier AG, Fazleabas AT, Lessey BA, Guo H, Toole BP, Nowaak RA (2006) Extracellular matrix metalloproteinase inducer regulates metalloproteinases in human uterine endometrium. J Clin Endocrinol Metab 91:2358-2365
36. Mossop H, Linhares IM, Zhou X, Bongiovanni AM, Forney L, Ledger WJ, Witkin SS (2012) Effect of lactic acid on vaginal EMMPRIN production: implications for altered vaginal microbiota-related pathology. Reprod Sci 19Suppl:395A
37. Braundmeier AG, Dayger CA, Mehrotra P, Belton RJ Jr, Nowak RA (2012) EMMPRIN is secreted by human uterine epithelial cells in microvescicles and stimulates metalloproteinase production by human uterine fibroblast cells. Reprod Sci 19:1292-1301